Epithelial ovarian cancer is usually found in the advanced stage. The current state of the art surgery and
chemotherapy leads to complete release; However, the repetition rate is high. in many patients, the disease ends up being a
continuous period without symptoms and episodes of recurrence. A variety of targeted therapies and biological drugs, currently
under development, offer the promise of transforming ovarian cancer, the latest major studies in a variety of new conventional
therapies, and new therapies, recently approved and / or clinical trials.
